Selected article for: "inhibitory activity and replication infection"

Author: Guo, Jiao; Jia, Xiaoying; Liu, Yang; Wang, Shaobo; Cao, Junyuan; Zhang, Bo; Xiao, Gengfu; Wang, Wei
Title: Screening of Natural Extracts for Inhibitors against Japanese Encephalitis Virus Infection
  • Document date: 2020_2_21
  • ID: 161ck1i9_7
    Snippet: Ouabain and digoxin inhibit JEV infection during viral RNA synthesis. To determine the cellular process that these drugs target, a time-of-addition experiment was performed (Fig. 4A ). As shown in Fig. 4B , neither digoxin nor ouabain showed suppression of JEV in virucidal treatments or pretreatments. However, ouabain showed a robust inhibition of JEV during treatment. Most importantly, when added posttreatment, both ouabain and digoxin exerted f.....
    Document: Ouabain and digoxin inhibit JEV infection during viral RNA synthesis. To determine the cellular process that these drugs target, a time-of-addition experiment was performed (Fig. 4A ). As shown in Fig. 4B , neither digoxin nor ouabain showed suppression of JEV in virucidal treatments or pretreatments. However, ouabain showed a robust inhibition of JEV during treatment. Most importantly, when added posttreatment, both ouabain and digoxin exerted full inhibitory effects on JEV infection, suggesting that viral replication was the main stage at which these drugs showed inhibitory activity.

    Search related documents:
    Co phrase search for related documents
    • addition time and drug target: 1, 2, 3
    • addition time and inhibitory activity: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • addition time and inhibitory effect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • addition time and JEV infection: 1, 2
    • addition time and RNA synthesis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • addition time and viral replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41
    • addition time and viral RNA synthesis: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • addition time experiment and inhibitory activity: 1
    • addition time experiment and inhibitory effect: 1, 2, 3
    • addition time experiment and RNA synthesis: 1
    • addition time experiment and viral replication: 1, 2
    • addition time experiment and viral RNA synthesis: 1
    • cellular process and drug target: 1, 2
    • cellular process and inhibitory activity: 1, 2
    • cellular process and inhibitory effect: 1
    • cellular process and RNA synthesis: 1, 2, 3, 4, 5, 6
    • cellular process and viral replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
    • cellular process and viral RNA synthesis: 1, 2, 3
    • digoxin inhibit and ouabain digoxin: 1